Clinical trial
Pathogenesis of Adverse Drug Reactions
NCT00224952 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00224952 |
|---|---|
| Title | Pathogenesis of Adverse Drug Reactions |
| Official title | The Role of Drug Metabolizing Enzymes in the Pathogenesis Adverse Drug Reactions in Children |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH University of Utah University of Louisville |
| Status | Completed |
| Study type | Observational |
| Conditions | Seizures |
| Intervention type | Other |
| Interventions | No intervention, Urine Collection |
| Enrollment | 274 |
| Start date | Jul 1, 2002 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 23, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: